CALLIE HUBBARD: Open Payments
NPI 1144959008 · MABANK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 28 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $332 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $87 |
| Lilly USA, LLC | 4 | $65 |
| ABIOMED | 2 | $64 |
| ABBVIE INC. | 3 | $58 |
| Novo Nordisk Inc | 2 | $44 |
| SANOFI-AVENTIS U.S. LLC | 1 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Astellas Pharma US Inc | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $26 |
Products named: ELIQUIS, JARDIANCE, MOUNJARO, VRAYLAR, TZIELD, Veozah, Cologuard Collection Kit, Ozempic.
Industry payments across TX — which companies pay providers there.
